Answers are grounded in this paper and cite their sources.
Background Platelet hyperactivation and thrombo-inflammatory processes are critical drivers of cardiovascular diseases. Although conventional antiplatelet therapies reduce thrombotic risk, their use is limited by bleeding complications and drug resistance. Ginsenoside Rs3 (G-Rs3) exhibits anti-inflammatory potential; however, the specific mechanisms underlying the antiplatelet and thrombo-inflammatory activity of ginsenoside Rs3 (G-Rs3) remain unclear. Methods Human platelets were treated with G-Rs3 in vitro to evaluate its effects on aggregation, intracellular signaling, granule secretion, and thrombo-inflammatory signaling markers. Network pharmacological analyses were performed to predict pathway-level modulations. The in vivo antithrombotic efficacy of G-Rs3 was assessed using a murine FeCl 3 -induced thrombosis model. Results G-Rs3 inhibited platelet aggregation in a dose-dependent manner following stimulation with collagen, thrombin, and U46619. It suppressed Ca 2+ mobilization, dense granule secretion, and phosphorylation of key signaling molecules, including InsP 3 R, ERK1/2, MAPKs, PI3K, Akt, GSK3, and Syk. Additionally, G-Rs3 inhibited integrin αIIbβ3 activation, reduced platelet adhesion, and enhanced cyclic nucleotide–mediated negative regulation, as evidenced by elevated VASP phosphorylation and increased cAMP/cGMP levels. Notably, G-Rs3 attenuated oxLDL-enhanced upregulation of the pro-inflammatory platelet markers CD62P and CD162, highlighting its potential to suppress platelet-driven thrombo-inflammatory responses under atherogenic conditions. Further, network pharmacology analysis revealed that G-Rs3 targets multiple interconnected thrombo-inflammatory pathways, including MAPK, PI3K-Akt, Ras, calcium, and cyclic nucleotide signaling. In vivo , G-Rs3 significantly delayed thrombus formation and moderately prolonged occlusion time. Conclusion These findings highlight G-Rs3 as a novel natural antithrombotic agent with anti-thrombo-inflammatory properties. Further studies are required to determine its translational potential and establish its therapeutic viability and safety profile.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: